CCL2 and neoplasm: Recent research has also revealed that ETV4 plays a crucial role in modulating the tumor microenvironment, particularly by upregulating PD-L1 and CCL2, which leads to increased infiltration of immunosuppressive cells such as tumor-associated macrophages (TAMs) and myeloid-derived suppressor cells (MDSCs).